MedPath

Feasibility study of nonmyeloablative allogeneic stem cell transplantation as a consolidation after autologous peripheral blood stem cell transplantation for multiple myeloma with poor prognosis

Not Applicable
Conditions
Multiple myeloma
Registration Number
JPRN-UMIN000001962
Lead Sponsor
agoya Blood and Marrow Transplantation Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
22
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Positive for HIV antibody, HBs antigen and/or HBe antigen (2)Pregnant or during breast feeding (3)Other active cancer (4)Active psychiatric disease (5)Active infection (6)Allergic history to drugs used in the present conditioning regimen or GVHD prophylaxis regimen. (7)Cases that physicians judged as inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath